Although Vietnam has a treasure of abundant and diverse sources of pharmaceutical materials, including nearly 4,000 herbal plants, the country's pharmaceutical industry currently depends on material imported from China to make up medicines. To exploit its own resources, it is necessary for Vietnam to boost investments in hi-tech extraction technologies.
Latest statistical reports from the Drug Administration of Vietnam indicated that in 2008, locally-produced medicines meet just 50.18 percent of demand, with eighty percent of materials for the production of medicine imported from foreign countries, mainly from China.
At present, BV Pharma can produce mangiferin with a purity of 98 and 100 percent. The volume of material and medicines in the form of finished products exported to Russia is worth $1 million a year.
|By Staff writers – Translated by Phuong Lan|